A Closer Look at the Lecanemab Clinical Trials | Special Video Episode of Dementia Matters
Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval
Putting Lecanemab into Practice: A Clinician’s Perspective on the New Alzheimer’s Treatment
Making and Unmaking Dementia: A History and a Future
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease
Liana Apostolova OBD Guest Speaker (long version)
New Alzheimer's treatment approved by FDA after clinical trial at UK
UK Alzheimer’s Society opens new grant funding round
Research connects I Enhancing dementia research literacy in the age of (mis)information
Dealing with Health Inequalities, and help after a Dementia Diagnosis
Smart Brain Imaging to understand Dementia
Inspiring Careers in Dementia Research - Professor John Gallacher
Loveday: A Historic Moment in Alzheimer's Disease (Full Version)
A ’Manhattan Project’ for the mind
Leveraging Alzheimer’s Disease Clinical Trial Outcomes in Health Economics Research
How is research making a visit to the hospital better for people living with dementia
Improving Registries and Representation in Alzheimer’s Disease Research
Getting to know the 'Dementias Platform UK' data portal - LIVE Podcast Recording
Nathan Stephens - Social Value: a vehicle for social change
World Alzheimer Report 2021: Diagnosis and health system preparedness (Webinar)
